{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T19:38:54Z","timestamp":1789414734372,"version":"build-2803163510"},"reference-count":221,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s13555-026-01807-w","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:36:13Z","timestamp":1780461373000},"page":"3385-3414","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Decoding Hyperpigmentation from Biological Mechanisms to Actives with Clinically Proven Topical Efficacy: A Narrative Review"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0982-2177","authenticated-orcid":false,"given":"Christine","family":"Duval","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9149-3550","authenticated-orcid":false,"given":"Jie","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7589-7965","authenticated-orcid":false,"given":"Emilie","family":"Warrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8710-6582","authenticated-orcid":false,"given":"Peggy","family":"Sextius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8540-0834","authenticated-orcid":false,"given":"Isabelle","family":"Castiel-Higounenc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2080-0550","authenticated-orcid":false,"given":"Leihong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5426-7948","authenticated-orcid":false,"given":"Francoise","family":"Bernerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0797-6570","authenticated-orcid":false,"given":"Thierry","family":"Passeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,3]]},"reference":[{"key":"1807_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2024.07.1114","volume":"91","author":"DK Kerob","year":"2024","unstructured":"Kerob DK, Passeron T, Alexis A, et al. 54772 pigmentary disorders, prevalence, impact on quality of life and social stigmatization: results of the first large international survey. J Am Acad Dermatol. 2024;91:AB280. https:\/\/doi.org\/10.1016\/j.jaad.2024.07.1114.","journal-title":"J Am Acad Dermatol"},{"issue":"388","key":"1807_CR2","first-page":"390","volume":"32","author":"RM Halder","year":"1983","unstructured":"Halder RM, Grimes PE, McLaurin CI, Kress MA, Kenney JA. Incidence of common dermatoses in a predominantly black dermatologic practice. Cutis. 1983;32(388):390.","journal-title":"Cutis"},{"key":"1807_CR3","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1590\/abd1806-4841.20143063","volume":"89","author":"AC Handel","year":"2014","unstructured":"Handel AC, Miot LDB, Miot HA. Melasma: a clinical and epidemiological review. An Bras Dermatol. 2014;89:771\u201382. https:\/\/doi.org\/10.1590\/abd1806-4841.20143063.","journal-title":"An Bras Dermatol"},{"key":"1807_CR4","doi-asserted-by":"publisher","first-page":"184","DOI":"10.36849\/JDD.2020.4663","volume":"19","author":"K Kagha","year":"2020","unstructured":"Kagha K, Fabi S, Goldman M. Melasma\u2019s impact on quality of life. J Drugs Dermatol. 2020;19:184\u20137. https:\/\/doi.org\/10.36849\/JDD.2020.4663.","journal-title":"J Drugs Dermatol"},{"key":"1807_CR5","first-page":"387","volume":"80","author":"AF Alexis","year":"2007","unstructured":"Alexis AF, Sergay AB, Taylor SC. Common dermatologic disorders in skin of color: a comparative practice survey. Cutis. 2007;80:387\u201394.","journal-title":"Cutis"},{"key":"1807_CR6","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.1111\/jocd.15242","volume":"21","author":"VK Mahajan","year":"2022","unstructured":"Mahajan VK, Patil A, Blicharz L, et al. Medical therapies for melasma. J Cosmet Dermatol. 2022;21:3707\u201328. https:\/\/doi.org\/10.1111\/jocd.15242.","journal-title":"J Cosmet Dermatol"},{"key":"1807_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/bjd.21244","volume":"187","author":"A Pennitz","year":"2022","unstructured":"Pennitz A, Kinberger M, Avila Valle G, Passeron T, Nast A, Werner RN. Self-applied topical interventions for melasma: a systematic review and meta-analysis of data from randomized, investigator-blinded clinical trials. Br J Dermatol. 2022;187:309\u201317. https:\/\/doi.org\/10.1111\/bjd.21244.","journal-title":"Br J Dermatol"},{"key":"1807_CR8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/pcmr.12410","volume":"28","author":"S Del Bino","year":"2015","unstructured":"Del Bino S, Ito S, Sok J, et al. Chemical analysis of constitutive pigmentation of human epidermis reveals constant eumelanin to pheomelanin ratio. Pigment Cell Melanoma Res. 2015;28:707\u201317. https:\/\/doi.org\/10.1111\/pcmr.12410.","journal-title":"Pigment Cell Melanoma Res"},{"key":"1807_CR9","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/pcmr.13062","volume":"35","author":"S Del Bino","year":"2022","unstructured":"Del Bino S, Ito S, Sok J, Wakamatsu K. 5,6-Dihydroxyindole eumelanin content in human skin with varying degrees of constitutive pigmentation. Pigment Cell Melanoma Res. 2022;35:622\u20136. https:\/\/doi.org\/10.1111\/pcmr.13062.","journal-title":"Pigment Cell Melanoma Res"},{"key":"1807_CR10","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/ahg.70003","volume":"89","author":"P Manga","year":"2025","unstructured":"Manga P, Loftus S. Genetics of skin, hair, and eye color in human pigmentation disorders. Ann Hum Genet. 2025;89:305\u201320. https:\/\/doi.org\/10.1111\/ahg.70003.","journal-title":"Ann Hum Genet"},{"key":"1807_CR11","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/ics.12466","volume":"40","author":"C Serre","year":"2018","unstructured":"Serre C, Busuttil V, Botto J-M. Intrinsic and extrinsic regulation of human skin melanogenesis and pigmentation. Int J Cosmet Sci. 2018;40:328\u201347. https:\/\/doi.org\/10.1111\/ics.12466.","journal-title":"Int J Cosmet Sci"},{"key":"1807_CR12","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.24625.1","volume":"9","author":"N Ohbayashi","year":"2020","unstructured":"Ohbayashi N, Fukuda M. Recent advances in understanding the molecular basis of melanogenesis in melanocytes. F1000Res. 2020;9:608. https:\/\/doi.org\/10.12688\/f1000research.24625.1.","journal-title":"F1000Res"},{"key":"1807_CR13","doi-asserted-by":"publisher","first-page":"5622","DOI":"10.1073\/pnas.1600108113","volume":"113","author":"AL Ambrosio","year":"2016","unstructured":"Ambrosio AL, Boyle JA, Aradi AE, Christian KA, Di Pietro SM. TPC2 controls pigmentation by regulating melanosome pH and size. Proc Natl Acad Sci USA. 2016;113:5622\u20137. https:\/\/doi.org\/10.1073\/pnas.1600108113.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1807_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.abb.2014.06.020","volume":"563","author":"NW Bellono","year":"2014","unstructured":"Bellono NW, Oancea EV. Ion transport in pigmentation. Arch Biochem Biophys. 2014;563:35\u201341. https:\/\/doi.org\/10.1016\/j.abb.2014.06.020.","journal-title":"Arch Biochem Biophys"},{"key":"1807_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25071537","volume":"25","author":"F Solano","year":"2020","unstructured":"Solano F. Photoprotection and skin pigmentation: melanin-related molecules and some other new agents obtained from natural sources. Molecules. 2020;25:1537. https:\/\/doi.org\/10.3390\/molecules25071537.","journal-title":"Molecules"},{"key":"1807_CR16","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nature11624","volume":"491","author":"D Mitra","year":"2012","unstructured":"Mitra D, Luo X, Morgan A, et al. An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair\/fair skin background. Nature. 2012;491:449\u201353. https:\/\/doi.org\/10.1038\/nature11624.","journal-title":"Nature"},{"key":"1807_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19092668","volume":"19","author":"S Del Bino","year":"2018","unstructured":"Del Bino S, Duval C, Bernerd F. Clinical and biological characterization of skin pigmentation diversity and its consequences on UV impact. Int J Mol Sci. 2018;19:092668. https:\/\/doi.org\/10.3390\/ijms19092668.","journal-title":"Int J Mol Sci"},{"key":"1807_CR18","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/j.jid.2017.09.039","volume":"138","author":"I Hurbain","year":"2018","unstructured":"Hurbain I, Romao M, Sextius P, et al. Melanosome distribution in keratinocytes in different skin types: melanosome clusters are not degradative organelles. J Invest Dermatol. 2018;138:647\u201356. https:\/\/doi.org\/10.1016\/j.jid.2017.09.039.","journal-title":"J Invest Dermatol"},{"key":"1807_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22083970","volume":"22","author":"MR Hossain","year":"2021","unstructured":"Hossain MR, Ansary TM, Komine M, Ohtsuki M. Diversified stimuli-induced inflammatory pathways cause skin pigmentation. Int J Mol Sci. 2021;22:083970. https:\/\/doi.org\/10.3390\/ijms22083970.","journal-title":"Int J Mol Sci"},{"key":"1807_CR20","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1600-0749.2004.00131.x","volume":"17","author":"M Bastiaens","year":"2004","unstructured":"Bastiaens M, Hoefnagel J, Westendorp R, Vermeer B-J, Bouwes Bavinck JN. Solar lentigines are strongly related to sun exposure in contrast to ephelides. Pigment Cell Res. 2004;17:225\u20139. https:\/\/doi.org\/10.1111\/j.1600-0749.2004.00131.x.","journal-title":"Pigment Cell Res"},{"key":"1807_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jdermsci.2022.07.001","volume":"107","author":"E Warrick","year":"2022","unstructured":"Warrick E, Duval C, Nouveau S, et al. Actinic lentigines from Japanese and European volunteers share similar impaired biological functions. J Dermatol Sci. 2022;107:8\u201316. https:\/\/doi.org\/10.1016\/j.jdermsci.2022.07.001.","journal-title":"J Dermatol Sci"},{"key":"1807_CR22","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1111\/bjd.15697","volume":"177","author":"E Warrick","year":"2017","unstructured":"Warrick E, Duval C, Nouveau S, et al. Morphological and molecular characterization of actinic lentigos reveals alterations of the dermal extracellular matrix. Br J Dermatol. 2017;177:1619\u201332. https:\/\/doi.org\/10.1111\/bjd.15697.","journal-title":"Br J Dermatol"},{"key":"1807_CR23","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1111\/exd.14667","volume":"31","author":"K Miyachi","year":"2022","unstructured":"Miyachi K, Yamada T, Sanada A, et al. Melanin accumulation in dermal stem cells deteriorates their exosome-mediated skin basement membrane construction in solar lentigo. Exp Dermatol. 2022;31:1881\u201390. https:\/\/doi.org\/10.1111\/exd.14667.","journal-title":"Exp Dermatol"},{"key":"1807_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-53990-5","volume":"14","author":"C Duval","year":"2024","unstructured":"Duval C, Bourreau E, Warrick E, Bastien P, Nouveau S, Bernerd F. A chronic pro-inflammatory environment contributes to the physiopathology of actinic lentigines. Sci Rep. 2024;14:5256. https:\/\/doi.org\/10.1038\/s41598-024-53990-5.","journal-title":"Sci Rep"},{"key":"1807_CR25","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s40257-017-0333-6","volume":"19","author":"BP Kaufman","year":"2018","unstructured":"Kaufman BP, Aman T, Alexis AF. Postinflammatory hyperpigmentation: epidemiology, clinical presentation, pathogenesis and treatment. Am J Clin Dermatol. 2018;19:489\u2013503. https:\/\/doi.org\/10.1007\/s40257-017-0333-6.","journal-title":"Am J Clin Dermatol"},{"key":"1807_CR26","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/pcmr.12692","volume":"31","author":"T Passeron","year":"2018","unstructured":"Passeron T, Nouveau S, Duval C, et al. Development and validation of a reproducible model for studying post-inflammatory hyperpigmentation. Pigment Cell Melanoma Res. 2018;31:649\u201352. https:\/\/doi.org\/10.1111\/pcmr.12692.","journal-title":"Pigment Cell Melanoma Res"},{"key":"1807_CR27","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jaad.2017.01.036","volume":"77","author":"S Chaowattanapanit","year":"2017","unstructured":"Chaowattanapanit S, Silpa-archa N, Kohli I, Lim HW, Hamzavi I. Postinflammatory hyperpigmentation: a comprehensive overview. J Am Acad Dermatol. 2017;77:607\u201321. https:\/\/doi.org\/10.1016\/j.jaad.2017.01.036.","journal-title":"J Am Acad Dermatol"},{"key":"1807_CR28","doi-asserted-by":"publisher","first-page":"426","DOI":"10.4103\/2229-5178.142484","volume":"5","author":"R Sarkar","year":"2014","unstructured":"Sarkar R, Arora P, Garg VK, Sonthalia S, Gokhale N. Melasma update. Indian Dermatol Online J. 2014;5:426\u201335. https:\/\/doi.org\/10.4103\/2229-5178.142484.","journal-title":"Indian Dermatol Online J"},{"key":"1807_CR29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s13555-017-0194-1","volume":"7","author":"OA Ogbechie-Godec","year":"2017","unstructured":"Ogbechie-Godec OA, Elbuluk N. Melasma: an up-to-date comprehensive review. Dermatol Ther (Heidelb). 2017;7:305\u201318. https:\/\/doi.org\/10.1007\/s13555-017-0194-1.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1807_CR30","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1111\/pcmr.12684","volume":"31","author":"T Passeron","year":"2018","unstructured":"Passeron T, Picardo M. Melasma, a photoaging disorder. Pigment Cell Melanoma Res. 2018;31:461\u20135. https:\/\/doi.org\/10.1111\/pcmr.12684.","journal-title":"Pigment Cell Melanoma Res"},{"key":"1807_CR31","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00403-019-01979-w","volume":"312","author":"ACC Esp\u00f3sito","year":"2020","unstructured":"Esp\u00f3sito ACC, Brianezi G, de Souza NP, Santos DC, Miot LDB, Miot HA. Ultrastructural characterization of damage in the basement membrane of facial melasma. Arch Dermatol Res. 2020;312:223\u20137. https:\/\/doi.org\/10.1007\/s00403-019-01979-w.","journal-title":"Arch Dermatol Res"},{"key":"1807_CR32","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1007\/s13555-022-00779-x","volume":"12","author":"ACC Esp\u00f3sito","year":"2022","unstructured":"Esp\u00f3sito ACC, Cassiano DP, da Silva CN, et al. Update on melasma-Part I: pathogenesis. Dermatol Ther (Heidelb). 2022;12:1967\u201388. https:\/\/doi.org\/10.1007\/s13555-022-00779-x.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1807_CR33","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1039\/c9pp00425d","volume":"19","author":"S Narla","year":"2020","unstructured":"Narla S, Kohli I, Hamzavi IH, Lim HW. Visible light in photodermatology. Photochem Photobiol Sci. 2020;19:99\u2013104. https:\/\/doi.org\/10.1039\/c9pp00425d.","journal-title":"Photochem Photobiol Sci"},{"key":"1807_CR34","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1600-0846.2007.00238.x","volume":"13","author":"K-S Suh","year":"2007","unstructured":"Suh K-S, Roh H-J, Choi S-Y, et al. A long-term evaluation of erythema and pigmentation induced by ultraviolet radiations of different wavelengths. Skin Res Technol. 2007;13:360\u20138. https:\/\/doi.org\/10.1111\/j.1600-0846.2007.00238.x.","journal-title":"Skin Res Technol"},{"key":"1807_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158243","volume":"23","author":"F Bernerd","year":"2022","unstructured":"Bernerd F, Passeron T, Castiel I, Marionnet C. The damaging effects of long UVA (UVA1) rays: a major challenge to preserve skin health and integrity. Int J Mol Sci. 2022;23:158243. https:\/\/doi.org\/10.3390\/ijms23158243.","journal-title":"Int J Mol Sci"},{"key":"1807_CR36","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jid.2017.07.833","volume":"138","author":"C Regazzetti","year":"2018","unstructured":"Regazzetti C, Sormani L, Debayle D, et al. Melanocytes sense blue light and regulate pigmentation through Opsin-3. J Invest Dermatol. 2018;138:171\u20138. https:\/\/doi.org\/10.1016\/j.jid.2017.07.833.","journal-title":"J Invest Dermatol"},{"key":"1807_CR37","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jid.2024.07.034","volume":"145","author":"E Yu","year":"2025","unstructured":"Yu E, Oh SW, Park S-H, et al. The pigmentation of blue light is mediated by both melanogenesis activation and autophagy inhibition through OPN3-TRPV1. J Invest Dermatol. 2025;145:908-918.e6. https:\/\/doi.org\/10.1016\/j.jid.2024.07.034.","journal-title":"J Invest Dermatol"},{"key":"1807_CR38","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1039\/c9pp00366e","volume":"19","author":"S Narla","year":"2020","unstructured":"Narla S, Lim HW. Sunscreen: FDA regulation, and environmental and health impact. Photochem Photobiol Sci. 2020;19:66\u201370. https:\/\/doi.org\/10.1039\/c9pp00366e.","journal-title":"Photochem Photobiol Sci"},{"key":"1807_CR39","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/php.13208","volume":"96","author":"OP Egambaram","year":"2020","unstructured":"Egambaram OP, Kesavan Pillai S, Ray SS. Materials science challenges in skin UV protection: a review. Photochem Photobiol. 2020;96:779\u201397. https:\/\/doi.org\/10.1111\/php.13208.","journal-title":"Photochem Photobiol"},{"key":"1807_CR40","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3390\/ijms16010068","volume":"16","author":"C Marionnet","year":"2014","unstructured":"Marionnet C, Tricaud C, Bernerd F. Exposure to non-extreme solar UV daylight: spectral characterization, effects on skin and photoprotection. Int J Mol Sci. 2014;16:68\u201390. https:\/\/doi.org\/10.3390\/ijms16010068.","journal-title":"Int J Mol Sci"},{"key":"1807_CR41","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1111\/jdv.17242","volume":"35","author":"T Passeron","year":"2021","unstructured":"Passeron T, Lim HW, Goh C-L, et al. Photoprotection according to skin phototype and dermatoses: practical recommendations from an expert panel. J Eur Acad Dermatol Venereol. 2021;35:1460\u20139. https:\/\/doi.org\/10.1111\/jdv.17242.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1807_CR42","first-page":"39","volume":"647","author":"European Commission","year":"2006","unstructured":"European Commission. European Commission recommendation on the efficacy of sunscreen products and the claims made relating thereto. Br J Dermatol. 2006;647:39\u201343.","journal-title":"Br J Dermatol"},{"issue":"Suppl 1","key":"1807_CR43","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.4103\/0378-6323.97352","volume":"78","author":"D Moyal","year":"2012","unstructured":"Moyal D. Need for a well-balanced sunscreen to protect human skin from both ultraviolet A and ultraviolet B damage. Indian J Dermatol Venereol Leprol. 2012;78(Suppl 1):S24-30. https:\/\/doi.org\/10.4103\/0378-6323.97352.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"1807_CR44","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jaad.2021.12.019","volume":"86","author":"DS Rigel","year":"2022","unstructured":"Rigel DS, Taylor SC, Lim HW, et al. Photoprotection for skin of all color: consensus and clinical guidance from an expert panel. J Am Acad Dermatol. 2022;86:S1-8. https:\/\/doi.org\/10.1016\/j.jaad.2021.12.019.","journal-title":"J Am Acad Dermatol"},{"key":"1807_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jphotobiol.2021.112372","volume":"227","author":"KP Lawrence","year":"2022","unstructured":"Lawrence KP, Sarkany RPE, Acker S, Herzog B, Young AR. A new visible light absorbing organic filter offers superior protection against pigmentation by wavelengths at the UVR-visible boundary region. J Photochem Photobiol B. 2022;227:112372. https:\/\/doi.org\/10.1016\/j.jphotobiol.2021.112372.","journal-title":"J Photochem Photobiol B"},{"key":"1807_CR46","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s43630-021-00114-x","volume":"20","author":"D Bacqueville","year":"2021","unstructured":"Bacqueville D, Jacques-Jamin C, Dromigny H, et al. Phenylene bis-diphenyltriazine (TriAsorB), a new sunfilter protecting the skin against both UVB\u2009+\u2009UVA and blue light radiations. Photochem Photobiol Sci. 2021;20:1475\u201386. https:\/\/doi.org\/10.1007\/s43630-021-00114-x.","journal-title":"Photochem Photobiol Sci"},{"issue":"1","key":"1807_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjidi.2021.100070","volume":"2","author":"C Marionnet","year":"2022","unstructured":"Marionnet C, de Dormael R, Marat X, et al. Sunscreens with the new MCE filter cover the whole UV spectrum: improved UVA1 photoprotection in vitro and in a randomized controlled trial. JID Innov. 2022;2(1):100070. https:\/\/doi.org\/10.1016\/j.xjidi.2021.100070.","journal-title":"JID Innov"},{"key":"1807_CR48","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/jdv.19486","volume":"38","author":"F Flament","year":"2024","unstructured":"Flament F, Mercurio DG, Muller B, et al. The impact of methoxypropylamino cyclohexenylidene ethoxyethylcyanoacetate (MCE) UVA1 filter on pigmentary and ageing signs: an outdoor prospective 8-week randomized, intra-individual comparative study in two populations of different genetic background. J Eur Acad Dermatol Venereol. 2024;38:214\u201322. https:\/\/doi.org\/10.1111\/jdv.19486.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1807_CR49","doi-asserted-by":"publisher","first-page":"6021","DOI":"10.1111\/jocd.15086","volume":"21","author":"R de Dormael","year":"2022","unstructured":"de Dormael R, Gueniche A, Bastien P, Verschoore M. Combining the use of two non-invasive instruments to confirm that a formula can improve skin luminance while respecting constitutive melanogenesis. J Cosmet Dermatol. 2022;21:6021\u20136. https:\/\/doi.org\/10.1111\/jocd.15086.","journal-title":"J Cosmet Dermatol"},{"key":"1807_CR50","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/phpp.12086","volume":"30","author":"JP Castanedo-Cazares","year":"2014","unstructured":"Castanedo-Cazares JP, Hernandez-Blanco D, Carlos-Ortega B, Fuentes-Ahumada C, Torres-\u00c1lvarez B. Near-visible light and UV photoprotection in the treatment of melasma: a double-blind randomized trial. Photodermatol Photoimmunol Photomed. 2014;30:35\u201342. https:\/\/doi.org\/10.1111\/phpp.12086.","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"1807_CR51","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/phpp.12377","volume":"34","author":"APM Martini","year":"2018","unstructured":"Martini APM, Maia Campos PMBG. Influence of visible light on cutaneous hyperchromias: clinical efficacy of broad-spectrum sunscreens. Photodermatol Photoimmunol Photomed. 2018;34:241\u20138. https:\/\/doi.org\/10.1111\/phpp.12377.","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"1807_CR52","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4103\/ijd.IJD_295_18","volume":"65","author":"S Fatima","year":"2020","unstructured":"Fatima S, Braunberger T, Mohammad TF, Kohli I, Hamzavi IH. The role of sunscreen in melasma and postinflammatory hyperpigmentation. Indian J Dermatol. 2020;65:5\u201310. https:\/\/doi.org\/10.4103\/ijd.IJD_295_18.","journal-title":"Indian J Dermatol"},{"key":"1807_CR53","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jaad.2014.08.023","volume":"72","author":"F Boukari","year":"2015","unstructured":"Boukari F, Jourdan E, Fontas E, et al. Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: a prospective randomized comparative trial. J Am Acad Dermatol. 2015;72:189-90.e1. https:\/\/doi.org\/10.1016\/j.jaad.2014.08.023.","journal-title":"J Am Acad Dermatol"},{"key":"1807_CR54","first-page":"55","volume":"93","author":"K Suozzi","year":"2020","unstructured":"Suozzi K, Turban J, Girardi M. Cutaneous photoprotection: a review of the current status and evolving strategies. Yale J Biol Med. 2020;93:55\u201367.","journal-title":"Yale J Biol Med"},{"key":"1807_CR55","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1111\/phpp.12423","volume":"35","author":"AF Nahhas","year":"2019","unstructured":"Nahhas AF, Abdel-Malek ZA, Kohli I, Braunberger TL, Lim HW, Hamzavi IH. The potential role of antioxidants in mitigating skin hyperpigmentation resulting from ultraviolet and visible light-induced oxidative stress. Photodermatol Photoimmunol Photomed. 2019;35:420\u20138. https:\/\/doi.org\/10.1111\/phpp.12423.","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"1807_CR56","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/ics.12728","volume":"43","author":"J Chen","year":"2021","unstructured":"Chen J, Liu Y, Zhao Z, Qiu J. Oxidative stress in the skin: impact and related protection. Int J Cosmet Sci. 2021;43:495\u2013509. https:\/\/doi.org\/10.1111\/ics.12728.","journal-title":"Int J Cosmet Sci"},{"key":"1807_CR57","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/ijd.13695","volume":"56","author":"V Choubey","year":"2017","unstructured":"Choubey V, Sarkar R, Garg V, Kaushik S, Ghunawat S, Sonthalia S. Role of oxidative stress in melasma: a prospective study on serum and blood markers of oxidative stress in melasma patients. Int J Dermatol. 2017;56:939\u201343. https:\/\/doi.org\/10.1111\/ijd.13695.","journal-title":"Int J Dermatol"},{"key":"1807_CR58","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/ijd.14827","volume":"59","author":"R Sarkar","year":"2020","unstructured":"Sarkar R, Devadasan S, Choubey V, Goswami B. Melatonin and oxidative stress in melasma - an unexplored territory; a prospective study. Int J Dermatol. 2020;59:572\u20135. https:\/\/doi.org\/10.1111\/ijd.14827.","journal-title":"Int J Dermatol"},{"key":"1807_CR59","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1038\/jid.2011.476","volume":"132","author":"F Liebel","year":"2012","unstructured":"Liebel F, Kaur S, Ruvolo E, Kollias N, Southall MD. Irradiation of skin with visible light induces reactive oxygen species and matrix-degrading enzymes. J Invest Dermatol. 2012;132:1901\u20137. https:\/\/doi.org\/10.1038\/jid.2011.476.","journal-title":"J Invest Dermatol"},{"key":"1807_CR60","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1529-8019.2012.01505.x","volume":"25","author":"C Oresajo","year":"2012","unstructured":"Oresajo C, Pillai S, Manco M, Yatskayer M, McDaniel D. Antioxidants and the skin: understanding formulation and efficacy. Dermatol Ther. 2012;25:252\u20139. https:\/\/doi.org\/10.1111\/j.1529-8019.2012.01505.x.","journal-title":"Dermatol Ther"},{"key":"1807_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/antiox8090379","volume":"8","author":"YC Boo","year":"2019","unstructured":"Boo YC. Can plant phenolic compounds protect the skin from airborne particulate matter? Antioxidants. 2019;8:379. https:\/\/doi.org\/10.3390\/antiox8090379.","journal-title":"Antioxidants"},{"key":"1807_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/life13071513","volume":"13","author":"A Rodr\u00edguez-Luna","year":"2023","unstructured":"Rodr\u00edguez-Luna A, Zamarr\u00f3n A, Juarranz \u00c1, Gonz\u00e1lez S. Clinical applications of Polypodium leucotomos (Fernblock\u00ae): an update. Life Basel. 2023;13:1513. https:\/\/doi.org\/10.3390\/life13071513.","journal-title":"Life Basel"},{"key":"1807_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/nu17071240","volume":"17","author":"P Ker\u0161manc","year":"2025","unstructured":"Ker\u0161manc P, Poga\u010dnik T, \u017dmitek J, Hristov H, To\u010dkova O, \u017dmitek K. Effects of eight-week supplementation containing red orange and Polypodium leucotomos extracts on UVB-induced skin responses: a randomized double-blind placebo-controlled trial. Nutrients. 2025;17:1240. https:\/\/doi.org\/10.3390\/nu17071240.","journal-title":"Nutrients"},{"key":"1807_CR64","first-page":"E53","volume":"12","author":"R De Dormael","year":"2019","unstructured":"De Dormael R, Bastien P, Sextius P, et al. Vitamin\u00a0C prevents ultraviolet-induced pigmentation in healthy volunteers: Bayesian meta-analysis results from 31 randomized controlled versus vehicle clinical studies. J Clin Aesthet Dermatol. 2019;12:E53\u20139.","journal-title":"J Clin Aesthet Dermatol"},{"key":"1807_CR65","doi-asserted-by":"publisher","first-page":"374","DOI":"10.4103\/jomfp.JOMFP_207_20","volume":"24","author":"RM Sanadi","year":"2020","unstructured":"Sanadi RM, Deshmukh RS. The effect of vitamin\u00a0C on melanin pigmentation - a systematic review. J Oral Maxillofac Pathol. 2020;24:374\u201382. https:\/\/doi.org\/10.4103\/jomfp.JOMFP_207_20.","journal-title":"J Oral Maxillofac Pathol"},{"key":"1807_CR66","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14095","volume":"33","author":"T Searle","year":"2020","unstructured":"Searle T, Al-Niaimi F, Ali FR. The top 10 cosmeceuticals for facial hyperpigmentation. Dermatol Ther. 2020;33:e14095. https:\/\/doi.org\/10.1111\/dth.14095.","journal-title":"Dermatol Ther"},{"key":"1807_CR67","doi-asserted-by":"publisher","first-page":"788","DOI":"10.36849\/JDD.2020.5079","volume":"19","author":"KM Babbush","year":"2020","unstructured":"Babbush KM, Babbush RA, Khachemoune A. The therapeutic use of antioxidants for melasma. J Drugs Dermatol. 2020;19:788\u201392. https:\/\/doi.org\/10.36849\/JDD.2020.5079.","journal-title":"J Drugs Dermatol"},{"key":"1807_CR68","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/ijd.15133","volume":"60","author":"KM Babbush","year":"2021","unstructured":"Babbush KM, Babbush RA, Khachemoune A. Treatment of melasma: a review of less commonly used antioxidants. Int J Dermatol. 2021;60:166\u201373. https:\/\/doi.org\/10.1111\/ijd.15133.","journal-title":"Int J Dermatol"},{"key":"1807_CR69","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1365-2230.2010.03916.x","volume":"36","author":"Y Wu","year":"2011","unstructured":"Wu Y, Matsui MS, Chen JZS, et al. Antioxidants add protection to a broad-spectrum sunscreen. Clin Exp Dermatol. 2011;36:178\u201387. https:\/\/doi.org\/10.1111\/j.1365-2230.2010.03916.x.","journal-title":"Clin Exp Dermatol"},{"key":"1807_CR70","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/php.12375","volume":"91","author":"S Grether-Beck","year":"2015","unstructured":"Grether-Beck S, Marini A, Jaenicke T, Krutmann J. Effective photoprotection of human skin against infrared A radiation by topically applied antioxidants: results from a vehicle controlled, double-blind, randomized study. Photochem Photobiol. 2015;91:248\u201350. https:\/\/doi.org\/10.1111\/php.12375.","journal-title":"Photochem Photobiol"},{"key":"1807_CR71","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000458158","volume":"30","author":"C Souza","year":"2017","unstructured":"Souza C, Maia Campos P, Schanzer S, et al. Radical-scavenging activity of a sunscreen enriched by antioxidants providing protection in the whole solar spectral range. Skin Pharmacol Physiol. 2017;30:81\u20139. https:\/\/doi.org\/10.1159\/000458158.","journal-title":"Skin Pharmacol Physiol"},{"key":"1807_CR72","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.drudis.2016.09.016","volume":"22","author":"T Pillaiyar","year":"2017","unstructured":"Pillaiyar T, Manickam M, Jung S-H. Downregulation of melanogenesis: drug discovery and therapeutic options. Drug Discov Today. 2017;22:282\u201398. https:\/\/doi.org\/10.1016\/j.drudis.2016.09.016.","journal-title":"Drug Discov Today"},{"key":"1807_CR73","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/14756366.2018.1545767","volume":"34","author":"S Zolghadri","year":"2019","unstructured":"Zolghadri S, Bahrami A, Hassan Khan MT, et al. A comprehensive review on tyrosinase inhibitors. J Enzyme Inhib Med Chem. 2019;34:279\u2013309. https:\/\/doi.org\/10.1080\/14756366.2018.1545767.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"1807_CR74","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.sder.2009.04.001","volume":"28","author":"PE Grimes","year":"2009","unstructured":"Grimes PE. Management of hyperpigmentation in darker racial ethnic groups. Semin Cutan Med Surg. 2009;28:77\u201385. https:\/\/doi.org\/10.1016\/j.sder.2009.04.001.","journal-title":"Semin Cutan Med Surg"},{"key":"1807_CR75","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1080\/09546634.2021.1914313","volume":"33","author":"N Neagu","year":"2022","unstructured":"Neagu N, Conforti C, Agozzino M, et al. Melasma treatment: a systematic review. J Dermatolog Treat. 2022;33:1816\u201337. https:\/\/doi.org\/10.1080\/09546634.2021.1914313.","journal-title":"J Dermatolog Treat"},{"key":"1807_CR76","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1080\/09546634.2021.1981814","volume":"33","author":"MG Tan","year":"2022","unstructured":"Tan MG, Kim WB, Jo CE, Nabieva K, Kirshen C, Ortiz AE. Topical treatment for postinflammatory hyperpigmentation: a systematic review. J Dermatol Treat. 2022;33:2518\u201326. https:\/\/doi.org\/10.1080\/09546634.2021.1981814.","journal-title":"J Dermatol Treat"},{"key":"1807_CR77","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/j.1468-3083.2006.01670.x","volume":"20","author":"JJ Nordlund","year":"2006","unstructured":"Nordlund JJ, Grimes PE, Ortonne JP. The safety of hydroquinone. J Eur Acad Dermatol Venereol. 2006;20:781\u20137. https:\/\/doi.org\/10.1111\/j.1468-3083.2006.01670.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1807_CR78","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/jocd.12987","volume":"19","author":"M Gheisari","year":"2020","unstructured":"Gheisari M, Dadkhahfar S, Olamaei E, Moghimi HR, Niknejad N, Najar NN. The efficacy and safety of topical 5% methimazole vs 4% hydroquinone in the treatment of melasma: a randomized controlled trial. J Cosmet Dermatol. 2020;19:167\u201372. https:\/\/doi.org\/10.1111\/jocd.12987.","journal-title":"J Cosmet Dermatol"},{"key":"1807_CR79","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s13555-017-0195-0","volume":"7","author":"N Atefi","year":"2017","unstructured":"Atefi N, Dalvand B, Ghassemi M, Mehran G, Heydarian A. Therapeutic effects of topical tranexamic acid in comparison with hydroquinone in treatment of women with melasma. Dermatol Ther (Heidelb). 2017;7:417\u201324. https:\/\/doi.org\/10.1007\/s13555-017-0195-0.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1807_CR80","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/jocd.12143","volume":"14","author":"ZA Ibrahim","year":"2015","unstructured":"Ibrahim ZA, Gheida SF, El Maghraby GM, Farag ZE. Evaluation of the efficacy and safety of combinations of hydroquinone, glycolic acid, and hyaluronic acid in the treatment of melasma. J Cosmet Dermatol. 2015;14:113\u201323. https:\/\/doi.org\/10.1111\/jocd.12143.","journal-title":"J Cosmet Dermatol"},{"key":"1807_CR81","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10071129","volume":"10","author":"YC Boo","year":"2021","unstructured":"Boo YC. Arbutin as a skin depigmenting agent with antimelanogenic and antioxidant properties. Antioxidants (Basel). 2021;10:1129. https:\/\/doi.org\/10.3390\/antiox10071129.","journal-title":"Antioxidants (Basel)"},{"key":"1807_CR82","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/ics.12626","volume":"42","author":"WG Philipp-Dormston","year":"2020","unstructured":"Philipp-Dormston WG, Vila Echag\u00fce A, P\u00e9rez Damonte SH, et al. Thiamidol containing treatment regimens in facial hyperpigmentation: an international multi-centre approach consisting of a double-blind, controlled, split-face study and of an open-label, real-world study. Int J Cosmet Sci. 2020;42:377\u201387. https:\/\/doi.org\/10.1111\/ics.12626.","journal-title":"Int J Cosmet Sci"},{"key":"1807_CR83","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1111\/1346-8138.16080","volume":"48","author":"D Roggenkamp","year":"2021","unstructured":"Roggenkamp D, Sammain A, F\u00fcrstenau M, Kausch M, Passeron T, Kolbe L. Thiamidol\u00ae in moderate-to-severe melasma: 24-week, randomized, double-blind, vehicle-controlled clinical study with subsequent regression phase. J Dermatol. 2021;48:1871\u20136. https:\/\/doi.org\/10.1111\/1346-8138.16080.","journal-title":"J Dermatol"},{"key":"1807_CR84","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/ics.12694","volume":"43","author":"D Roggenkamp","year":"2021","unstructured":"Roggenkamp D, Dlova N, Mann T, et al. Effective reduction of post-inflammatory hyperpigmentation with the tyrosinase inhibitor isobutylamido-thiazolyl-resorcinol (Thiamidol). Int J Cosmet Sci. 2021;43:292\u2013301. https:\/\/doi.org\/10.1111\/ics.12694.","journal-title":"Int J Cosmet Sci"},{"key":"1807_CR85","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/j.jid.2019.02.013","volume":"139","author":"C Arrowitz","year":"2019","unstructured":"Arrowitz C, Schoelermann AM, Mann T, Jiang LI, Weber T, Kolbe L. Effective tyrosinase inhibition by Thiamidol results in significant improvement of mild to moderate melasma. J Invest Dermatol. 2019;139:1691-1698.e6. https:\/\/doi.org\/10.1016\/j.jid.2019.02.013.","journal-title":"J Invest Dermatol"},{"key":"1807_CR86","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1473-2165.2011.00573.x","volume":"10","author":"MH Gold","year":"2011","unstructured":"Gold MH, Biron J. Efficacy of a novel hydroquinone-free skin-brightening cream in patients with melasma. J Cosmet Dermatol. 2011;10:189\u201396. https:\/\/doi.org\/10.1111\/j.1473-2165.2011.00573.x.","journal-title":"J Cosmet Dermatol"},{"key":"1807_CR87","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/jocd.12025","volume":"12","author":"F Dreher","year":"2013","unstructured":"Dreher F, Draelos ZD, Gold MH, Goldman MP, Fabi SG, Puissegur Lupo ML. Efficacy of hydroquinone-free skin-lightening cream for photoaging. J Cosmet Dermatol. 2013;12:12\u20137. https:\/\/doi.org\/10.1111\/jocd.12025.","journal-title":"J Cosmet Dermatol"},{"key":"1807_CR88","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19020552","author":"S Ito","year":"2018","unstructured":"Ito S, Wakamatsu K. Biochemical mechanism of rhododendrol-induced leukoderma. Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms19020552.","journal-title":"Int J Mol Sci"},{"key":"1807_CR89","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.jdermsci.2018.06.007","volume":"91","author":"Y Gabe","year":"2018","unstructured":"Gabe Y, Miyaji A, Kohno M, Hachiya A, Moriwaki S, Baba T. Substantial evidence for the rhododendrol-induced generation of hydroxyl radicals that causes melanocyte cytotoxicity and induces chemical leukoderma. J Dermatol Sci. 2018;91:311\u20136. https:\/\/doi.org\/10.1016\/j.jdermsci.2018.06.007.","journal-title":"J Dermatol Sci"},{"key":"1807_CR90","first-page":"19","volume":"15","author":"V Gonz\u00e1lez-Molina","year":"2022","unstructured":"Gonz\u00e1lez-Molina V, Mart\u00ed-Pineda A, Gonz\u00e1lez N. Topical treatments for melasma and their mechanism of action. J Clin Aesthet Dermatol. 2022;15:19\u201328.","journal-title":"J Clin Aesthet Dermatol"},{"key":"1807_CR91","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1111\/jocd.14494","volume":"20","author":"N Ahramiyanpour","year":"2021","unstructured":"Ahramiyanpour N, Saki N, Akbari Z, Shamsi-Meymandi S, Amiri R, Heiran A. Efficacy of topical cysteamine hydrochloride in treating melasma: a systematic review. J Cosmet Dermatol. 2021;20:3593\u2013602. https:\/\/doi.org\/10.1111\/jocd.14494.","journal-title":"J Cosmet Dermatol"},{"key":"1807_CR92","doi-asserted-by":"publisher","first-page":"e41","DOI":"10.1111\/ajd.13432","volume":"62","author":"J Nguyen","year":"2021","unstructured":"Nguyen J, Remyn L, Chung IY, et al. Evaluation of the efficacy of cysteamine cream compared to hydroquinone in the treatment of melasma: a randomised, double-blinded trial. Australas J Dermatol. 2021;62:e41\u20136. https:\/\/doi.org\/10.1111\/ajd.13432.","journal-title":"Australas J Dermatol"},{"key":"1807_CR93","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.36849\/jdd.6367","volume":"20","author":"S Desai","year":"2021","unstructured":"Desai S, Hartman C, Grimes P, Shah S. Topical stabilized cysteamine as a new treatment for hyperpigmentation disorders: melasma, post-inflammatory hyperpigmentation, and lentigines. J Drugs Dermatol. 2021;20:1276\u20139. https:\/\/doi.org\/10.36849\/jdd.6367.","journal-title":"J Drugs Dermatol"},{"key":"1807_CR94","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jaad.2011.06.001","volume":"65","author":"VM Sheth","year":"2011","unstructured":"Sheth VM, Pandya AG. Melasma: a comprehensive update: Part II. J Am Acad Dermatol. 2011;65:699\u2013714. https:\/\/doi.org\/10.1016\/j.jaad.2011.06.001.","journal-title":"J Am Acad Dermatol"},{"key":"1807_CR95","doi-asserted-by":"publisher","DOI":"10.3390\/antiox8090332","volume":"8","author":"YC Boo","year":"2019","unstructured":"Boo YC. Human skin lightening efficacy of resveratrol and its analogs: from in vitro studies to cosmetic applications. Antioxidants (Basel). 2019;8:332. https:\/\/doi.org\/10.3390\/antiox8090332.","journal-title":"Antioxidants (Basel)"},{"key":"1807_CR96","first-page":"14","volume":"14","author":"A Farag","year":"2021","unstructured":"Farag A, Hammam M, Alnaidany N, et al. Methimazole in the treatment of melasma: a clinical and dermascopic study. J Clin Aesthet Dermatol. 2021;14:14\u201320.","journal-title":"J Clin Aesthet Dermatol"},{"key":"1807_CR97","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1529-8019.2012.01540.x","volume":"26","author":"J Malek","year":"2013","unstructured":"Malek J, Chedraoui A, Nikolic D, Barouti N, Ghosn S, Abbas O. Successful treatment of hydroquinone-resistant melasma using topical methimazole. Dermatol Ther. 2013;26:69\u201372. https:\/\/doi.org\/10.1111\/j.1529-8019.2012.01540.x.","journal-title":"Dermatol Ther"},{"key":"1807_CR98","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1159\/000148222","volume":"21","author":"B Kasraee","year":"2008","unstructured":"Kasraee B, Safaee Ardekani GH, Parhizgar A, et al. Safety of topical methimazole for the treatment of melasma. Skin Pharmacol Physiol. 2008;21:300\u20135. https:\/\/doi.org\/10.1159\/000148222.","journal-title":"Skin Pharmacol Physiol"},{"key":"1807_CR99","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1038\/jid.2014.202","volume":"134","author":"A Lehraiki","year":"2014","unstructured":"Lehraiki A, Abbe P, Cerezo M, et al. Inhibition of melanogenesis by the antidiabetic metformin. J Invest Dermatol. 2014;134:2589\u201397. https:\/\/doi.org\/10.1038\/jid.2014.202.","journal-title":"J Invest Dermatol"},{"key":"1807_CR100","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1111\/jocd.13145","volume":"19","author":"R Banavase Channakeshavaiah","year":"2020","unstructured":"Banavase Channakeshavaiah R, Andanooru Chandrappa NK. Topical metformin in the treatment of melasma: a preliminary clinical trial. J Cosmet Dermatol. 2020;19:1161\u20134. https:\/\/doi.org\/10.1111\/jocd.13145.","journal-title":"J Cosmet Dermatol"},{"key":"1807_CR101","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.1111\/jocd.14953","volume":"21","author":"ES AboAlsoud","year":"2022","unstructured":"AboAlsoud ES, Eldahshan RM, AbouKhodair Mohammed H, Elsaie ML. Safety and efficacy of topical metformin 30% cream versus triple combination cream (Kligman\u2019s formula) in treating melasma: a randomized controlled study. J Cosmet Dermatol. 2022;21:2508\u201315. https:\/\/doi.org\/10.1111\/jocd.14953.","journal-title":"J Cosmet Dermatol"},{"key":"1807_CR102","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.7150\/thno.24385","volume":"8","author":"C-Y Yun","year":"2018","unstructured":"Yun C-Y, Mi Ko S, Pyo Choi Y, et al. \u03b1-Viniferin improves facial hyperpigmentation via accelerating feedback termination of cAMP\/PKA-signaled phosphorylation circuit in facultative melanogenesis. Theranostics. 2018;8:2031\u201343. https:\/\/doi.org\/10.7150\/thno.24385.","journal-title":"Theranostics"},{"key":"1807_CR103","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1055\/s-2003-42787","volume":"69","author":"EY Chung","year":"2003","unstructured":"Chung EY, Kim BH, Lee MK, et al. Anti-inflammatory effect of the oligomeric stilbene alpha-viniferin and its mode of the action through inhibition of cyclooxygenase-2 and inducible nitric oxide synthase. Planta Med. 2003;69:710\u20134. https:\/\/doi.org\/10.1055\/s-2003-42787.","journal-title":"Planta Med"},{"key":"1807_CR104","doi-asserted-by":"publisher","DOI":"10.5812\/jjnpp.114152","volume":"16","author":"M Jufri","year":"2021","unstructured":"Jufri M, Vardhani A, Purwaningsih E. Evaluating the efficacy of lotion containing black rice bran (Oryza sativa L. indica) extract as skin brightening agent: a clinical trial. Jundishapur J Nat Pharm Prod. 2021;16:e114152. https:\/\/doi.org\/10.5812\/jjnpp.114152.","journal-title":"Jundishapur J Nat Pharm Prod"},{"key":"1807_CR105","doi-asserted-by":"publisher","first-page":"C759","DOI":"10.1111\/j.1750-3841.2012.02763.x","volume":"77","author":"H-I Jun","year":"2012","unstructured":"Jun H-I, Song G-S, Yang E-I, Youn Y, Kim Y-S. Antioxidant activities and phenolic compounds of pigmented rice bran extracts. J Food Sci. 2012;77:C759\u201364. https:\/\/doi.org\/10.1111\/j.1750-3841.2012.02763.x.","journal-title":"J Food Sci"},{"key":"1807_CR106","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11746-009-1483-3","volume":"87","author":"GPP Kamatou","year":"2010","unstructured":"Kamatou GPP, Viljoen AM. A review of the application and pharmacological properties of \u03b1-bisabolol and \u03b1-bisabolol-rich oils. J Am Oil Chem Soc. 2010;87:1\u20137. https:\/\/doi.org\/10.1007\/s11746-009-1483-3.","journal-title":"J Am Oil Chem Soc"},{"key":"1807_CR107","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jdermsci.2008.06.005","volume":"52","author":"S Kim","year":"2008","unstructured":"Kim S, Lee J, Jung E, et al. Mechanisms of depigmentation by alpha-bisabolol. J Dermatol Sci. 2008;52:219\u201322. https:\/\/doi.org\/10.1016\/j.jdermsci.2008.06.005.","journal-title":"J Dermatol Sci"},{"key":"1807_CR108","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1468-2494.2010.00560.x","volume":"32","author":"J Lee","year":"2010","unstructured":"Lee J, Jun H, Jung E, Ha J, Park D. Whitening effect of alpha-bisabolol in Asian women subjects. Int J Cosmet Sci. 2010;32:299\u2013303. https:\/\/doi.org\/10.1111\/j.1468-2494.2010.00560.x.","journal-title":"Int J Cosmet Sci"},{"key":"1807_CR109","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1111\/jocd.13969","volume":"20","author":"SH Kim","year":"2021","unstructured":"Kim SH, Paik BR, Lee SH, et al. Clinical brightening efficacy and safety of Melasolv\u2122 (3,4,5-trimethoxy cinnamate thymol ester, TCTE) in Southeast Asian women. J Cosmet Dermatol. 2021;20:2851\u20139. https:\/\/doi.org\/10.1111\/jocd.13969.","journal-title":"J Cosmet Dermatol"},{"key":"1807_CR110","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/mt.2010.263","volume":"19","author":"X Yi","year":"2011","unstructured":"Yi X, Zhao G, Zhang H, et al. MITF-siRNA formulation is a safe and effective therapy for human melasma. Mol Ther. 2011;19:362\u201371. https:\/\/doi.org\/10.1038\/mt.2010.263.","journal-title":"Mol Ther"},{"key":"1807_CR111","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.jconrel.2015.09.017","volume":"219","author":"M Zakrewsky","year":"2015","unstructured":"Zakrewsky M, Kumar S, Mitragotri S. Nucleic acid delivery into skin for the treatment of skin disease: proofs-of-concept, potential impact, and remaining challenges. J Control Release. 2015;219:445\u201356. https:\/\/doi.org\/10.1016\/j.jconrel.2015.09.017.","journal-title":"J Control Release"},{"key":"1807_CR112","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1600-0625.2007.00675.x","volume":"17","author":"KU Schallreuter","year":"2008","unstructured":"Schallreuter KU, Kothari S, Chavan B, Spencer JD. Regulation of melanogenesis\u2013controversies and new concepts. Exp Dermatol. 2008;17:395\u2013404. https:\/\/doi.org\/10.1111\/j.1600-0625.2007.00675.x.","journal-title":"Exp Dermatol"},{"key":"1807_CR113","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.jdermsci.2011.06.002","volume":"63","author":"JS Hwang","year":"2011","unstructured":"Hwang JS, Lee HY, Lim T-Y, Kim MY, Yoon T-J. Disruption of tyrosinase glycosylation by N-acetylglucosamine and its depigmenting effects in guinea pig skin and in human skin. J Dermatol Sci. 2011;63:199\u2013201. https:\/\/doi.org\/10.1016\/j.jdermsci.2011.06.002.","journal-title":"J Dermatol Sci"},{"key":"1807_CR114","first-page":"18","volume":"26","author":"C Kindred","year":"2013","unstructured":"Kindred C, Okereke U, Callender VD. Skin-lightening agents: an overview of prescription, office-dispensed, and over-the-counter products. Cutis. 2013;26:18\u201326.","journal-title":"Cutis"},{"key":"1807_CR115","doi-asserted-by":"publisher","first-page":"16470","DOI":"10.1074\/jbc.274.23.16470","volume":"274","author":"HY Park","year":"1999","unstructured":"Park HY, Perez JM, Laursen R, Hara M, Gilchrest BA. Protein kinase C-beta activates tyrosinase by phosphorylating serine residues in its cytoplasmic domain. J Biol Chem. 1999;274:16470\u20138. https:\/\/doi.org\/10.1074\/jbc.274.23.16470.","journal-title":"J Biol Chem"},{"key":"1807_CR116","first-page":"s2","volume":"6","author":"K Lazou","year":"2007","unstructured":"Lazou K, Sadick NS, Kurfurst R, et al. The use of antisense strategy to modulate human melanogenesis. J Drugs Dermatol. 2007;6:s2-7.","journal-title":"J Drugs Dermatol"},{"key":"1807_CR117","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8080257","author":"YC Boo","year":"2020","unstructured":"Boo YC, Jo DJ, Oh CM, Lee SY, Kim YM. The first human clinical trial on the skin depigmentation efficacy of glycinamide hydrochloride. Biomedicines. 2020. https:\/\/doi.org\/10.3390\/biomedicines8080257.","journal-title":"Biomedicines"},{"key":"1807_CR118","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/jocd.12089","volume":"13","author":"A Katoulis","year":"2014","unstructured":"Katoulis A, Alevizou A, Soura E, et al. A double-blind vehicle-controlled study of a preparation containing undecylenoyl phenylalanine 2% in the treatment of melasma in females. J Cosmet Dermatol. 2014;13:86\u201390. https:\/\/doi.org\/10.1111\/jocd.12089.","journal-title":"J Cosmet Dermatol"},{"key":"1807_CR119","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1365-2230.2009.03605.x","volume":"35","author":"AC Katoulis","year":"2010","unstructured":"Katoulis AC, Alevizou A, Bozi E, et al. A randomized, double-blind, vehicle-controlled study of a preparation containing undecylenoyl phenylalanine 2% in the treatment of solar lentigines. Clin Exp Dermatol. 2010;35:473\u20136. https:\/\/doi.org\/10.1111\/j.1365-2230.2009.03605.x.","journal-title":"Clin Exp Dermatol"},{"key":"1807_CR120","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/pcmr.13168","volume":"37","author":"P Sextius","year":"2024","unstructured":"Sextius P, Warrick E, Pr\u00e9vot-Gu\u00e9guiniat A, et al. 2-Mercaptonicotinoyl glycine, a new potent melanogenesis inhibitor, exhibits a unique mode of action while preserving melanocyte integrity. Pigment Cell Melanoma Res. 2024;37:462\u201379. https:\/\/doi.org\/10.1111\/pcmr.13168.","journal-title":"Pigment Cell Melanoma Res"},{"key":"1807_CR121","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.16200","author":"R de Dormael","year":"2024","unstructured":"de Dormael R, Sextius P, Bourokba N, et al. 2-Mercaptonicotinoyl glycine prevents UV-induced skin darkening and delayed tanning in healthy subjects: a randomized controlled clinical study. J Cosmet Dermatol. 2024. https:\/\/doi.org\/10.1111\/jocd.16200.","journal-title":"J Cosmet Dermatol"},{"key":"1807_CR122","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1111\/jdv.19910","volume":"38","author":"B Muller","year":"2024","unstructured":"Muller B, Flament F, Jouni H, et al. A Bayesian network meta-analysis of 14 molecules inhibiting UV daylight-induced pigmentation. J Eur Acad Dermatol Venereol. 2024;38:1566\u201374. https:\/\/doi.org\/10.1111\/jdv.19910.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1807_CR123","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1651068","volume":"16","author":"V Piffaut","year":"2025","unstructured":"Piffaut V, De Dormael R, Belaidi J-P, et al. Topical prevention from high energy visible light-induced pigmentation by 2-mercaptonicotinoyl glycine, but not by ascorbic acid antioxidant: 2 randomized controlled trials. Front Pharmacol. 2025;16:1651068. https:\/\/doi.org\/10.3389\/fphar.2025.1651068.","journal-title":"Front Pharmacol"},{"key":"1807_CR124","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.24625.1","author":"N Ohbayashi","year":"2020","unstructured":"Ohbayashi N, Fukuda M. Recent advances in understanding the molecular basis of melanogenesis in melanocytes. F1000Res. 2020. https:\/\/doi.org\/10.12688\/f1000research.24625.1.","journal-title":"F1000Res"},{"key":"1807_CR125","doi-asserted-by":"publisher","DOI":"10.3390\/cells11132085","author":"KW Lee","year":"2022","unstructured":"Lee KW, Kim M, Lee SH, Kim KD. The function of autophagy as a regulator of melanin homeostasis. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11132085.","journal-title":"Cells"},{"key":"1807_CR126","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.bbrc.2017.02.033","volume":"485","author":"Y Katsuyama","year":"2017","unstructured":"Katsuyama Y, Taira N, Yoshioka M, Okano Y, Masaki H. Disruption of melanosome transport in melanocytes treated with theophylline causes their degradation by autophagy. Biochem Biophys Res Commun. 2017;485:126\u201330. https:\/\/doi.org\/10.1016\/j.bbrc.2017.02.033.","journal-title":"Biochem Biophys Res Commun"},{"key":"1807_CR127","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094466","author":"H Moreiras","year":"2021","unstructured":"Moreiras H, Seabra MC, Barral DC. Melanin transfer in the epidermis: the pursuit of skin pigmentation control mechanisms. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22094466.","journal-title":"Int J Mol Sci"},{"key":"1807_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ceb.2014.02.003","volume":"29","author":"X Wu","year":"2014","unstructured":"Wu X, Hammer JA. Melanosome transfer: it is best to give and receive. Curr Opin Cell Biol. 2014;29:1\u20137. https:\/\/doi.org\/10.1016\/j.ceb.2014.02.003.","journal-title":"Curr Opin Cell Biol"},{"key":"1807_CR129","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/j.1600-0854.2006.00425.x","volume":"7","author":"K Van Den Bossche","year":"2006","unstructured":"Van Den Bossche K, Naeyaert J-M, Lambert J. The quest for the mechanism of melanin transfer. Traffic. 2006;7:769\u201378. https:\/\/doi.org\/10.1111\/j.1600-0854.2006.00425.x.","journal-title":"Traffic"},{"key":"1807_CR130","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10081315","volume":"10","author":"YC Boo","year":"2021","unstructured":"Boo YC. Mechanistic basis and clinical evidence for the applications of nicotinamide (niacinamide) to control skin aging and pigmentation. Antioxidants. 2021;10:1315. https:\/\/doi.org\/10.3390\/antiox10081315.","journal-title":"Antioxidants"},{"key":"1807_CR131","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1046\/j.1523-1747.2000.00035.x","volume":"115","author":"M Seiberg","year":"2000","unstructured":"Seiberg M, Paine C, Sharlow E, et al. Inhibition of melanosome transfer results in skin lightening. J Invest Dermatol. 2000;115:162\u20137. https:\/\/doi.org\/10.1046\/j.1523-1747.2000.00035.x.","journal-title":"J Invest Dermatol"},{"key":"1807_CR132","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1468-2494.2010.00616.x","volume":"33","author":"JM Gillbro","year":"2011","unstructured":"Gillbro JM, Olsson MJ. The melanogenesis and mechanisms of skin-lightening agents\u2014existing and new approaches. Int J Cosmet Sci. 2011;33:210\u201321. https:\/\/doi.org\/10.1111\/j.1468-2494.2010.00616.x.","journal-title":"Int J Cosmet Sci"},{"key":"1807_CR133","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1046\/j.1523-1747.2001.01291.x","volume":"116","author":"C Paine","year":"2001","unstructured":"Paine C, Sharlow E, Liebel F, Eisinger M, Shapiro S, Seiberg M. An alternative approach to depigmentation by soybean extracts via inhibition of the PAR-2 pathway. J Invest Dermatol. 2001;116:587\u201395. https:\/\/doi.org\/10.1046\/j.1523-1747.2001.01291.x.","journal-title":"J Invest Dermatol"},{"key":"1807_CR134","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1159\/000063359","volume":"204","author":"JF Hermanns","year":"2002","unstructured":"Hermanns JF, Petit L, Pi\u00e9rard-Franchimont C, Paquet P, Pi\u00e9rard GE. Assessment of topical hypopigmenting agents on solar lentigines of Asian women. Dermatology. 2002;204:281\u20136. https:\/\/doi.org\/10.1159\/000063359.","journal-title":"Dermatology"},{"key":"1807_CR135","first-page":"917","volume":"6","author":"W Wallo","year":"2007","unstructured":"Wallo W, Nebus J, Leyden JJ. Efficacy of a soy moisturizer in photoaging: a double-blind, vehicle-controlled, 12-week study. J Drugs Dermatol. 2007;6:917\u201322.","journal-title":"J Drugs Dermatol"},{"key":"1807_CR136","first-page":"28","volume":"11","author":"JC Hollinger","year":"2018","unstructured":"Hollinger JC, Angra K, Halder RM. Are natural ingredients effective in the management of hyperpigmentation? A systematic review. J Clin Aesthet Dermatol. 2018;11:28\u201337.","journal-title":"J Clin Aesthet Dermatol"},{"key":"1807_CR137","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1046\/j.1365-2133.2002.04834.x","volume":"147","author":"T Hakozaki","year":"2002","unstructured":"Hakozaki T, Minwalla L, Zhuang J, et al. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer. Br J Dermatol. 2002;147:20\u201331. https:\/\/doi.org\/10.1046\/j.1365-2133.2002.04834.x.","journal-title":"Br J Dermatol"},{"key":"1807_CR138","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.0906-6705.2005.00309.x","volume":"14","author":"A Greatens","year":"2005","unstructured":"Greatens A, Hakozaki T, Koshoffer A, et al. Effective inhibition of melanosome transfer to keratinocytes by lectins and niacinamide is reversible. Exp Dermatol. 2005;14:498\u2013508. https:\/\/doi.org\/10.1111\/j.0906-6705.2005.00309.x.","journal-title":"Exp Dermatol"},{"key":"1807_CR139","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/ics.12759","volume":"44","author":"R Shariff","year":"2022","unstructured":"Shariff R, Du Y, Dutta M, et al. Superior even skin tone and anti-ageing benefit of a combination of 4-hexylresorcinol and niacinamide. Int J Cosmet Sci. 2022;44:103\u201317. https:\/\/doi.org\/10.1111\/ics.12759.","journal-title":"Int J Cosmet Sci"},{"key":"1807_CR140","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/379173","volume":"2011","author":"J Navarrete-Sol\u00eds","year":"2011","unstructured":"Navarrete-Sol\u00eds J, Castanedo-C\u00e1zares JP, Torres-\u00c1lvarez B, et al. A double-blind, randomized clinical trial of niacinamide 4% versus hydroquinone 4% in the treatment of melasma. Dermatol Res Pract. 2011;2011:379173. https:\/\/doi.org\/10.1155\/2011\/379173.","journal-title":"Dermatol Res Pract"},{"key":"1807_CR141","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/ics.12651","volume":"42","author":"JC Bierman","year":"2020","unstructured":"Bierman JC, Laughlin T, Tamura M, et al. Niacinamide mitigates SASP-related inflammation induced by environmental stressors in human epidermal keratinocytes and skin. Int J Cosmet Sci. 2020;42:501\u201311. https:\/\/doi.org\/10.1111\/ics.12651.","journal-title":"Int J Cosmet Sci"},{"key":"1807_CR142","doi-asserted-by":"publisher","DOI":"10.3390\/cells9122660","author":"\u0141 Szyma\u0144ski","year":"2020","unstructured":"Szyma\u0144ski \u0141, Skopek R, Palusi\u0144ska M, et al. Retinoic acid and its derivatives in skin. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9122660.","journal-title":"Cells"},{"key":"1807_CR143","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/srt.12877","volume":"26","author":"E Tancr\u00e8de-Bohin","year":"2020","unstructured":"Tancr\u00e8de-Bohin E, Baldeweck T, Brizion S, et al. In vivo multiphoton imaging for non-invasive time course assessment of retinoids effects on human skin. Skin Res Technol. 2020;26:794\u2013803. https:\/\/doi.org\/10.1111\/srt.12877.","journal-title":"Skin Res Technol"},{"key":"1807_CR144","doi-asserted-by":"publisher","first-page":"392","DOI":"10.5114\/ada.2019.87443","volume":"36","author":"M Zasada","year":"2019","unstructured":"Zasada M, Budzisz E. Retinoids: active molecules influencing skin structure formation in cosmetic and dermatological treatments. Postepy Dermatol Alergol. 2019;36:392\u20137. https:\/\/doi.org\/10.5114\/ada.2019.87443.","journal-title":"Postepy Dermatol Alergol"},{"issue":"Suppl 1","key":"1807_CR145","doi-asserted-by":"publisher","first-page":"S68","DOI":"10.1016\/s0923-1811(01)00116-5","volume":"27","author":"K Yoshimura","year":"2001","unstructured":"Yoshimura K, Tsukamoto K, Okazaki M, et al. Effects of all-trans retinoic acid on melanogenesis in pigmented skin equivalents and monolayer culture of melanocytes. J Dermatol Sci. 2001;27(Suppl 1):S68-75. https:\/\/doi.org\/10.1016\/s0923-1811(01)00116-5.","journal-title":"J Dermatol Sci"},{"key":"1807_CR146","unstructured":"Ho ET, Trookman NS, Sperber BR, et al. A randomized, double-blind, controlled comparative trial of the anti-aging properties of non-prescription tri-retinol 1.1% vs. prescription tretinoin 0.025%. J Drugs Dermatol. 2012;11:64\u20139."},{"key":"1807_CR147","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1529-8019.2006.00086.x","volume":"19","author":"O Sorg","year":"2006","unstructured":"Sorg O, Antille C, Kaya G, Saurat J-H. Retinoids in cosmeceuticals. Dermatol Ther. 2006;19:289\u201396. https:\/\/doi.org\/10.1111\/j.1529-8019.2006.00086.x.","journal-title":"Dermatol Ther"},{"key":"1807_CR148","doi-asserted-by":"publisher","first-page":"6636","DOI":"10.1111\/jocd.15420","volume":"21","author":"C Puyana","year":"2022","unstructured":"Puyana C, Chandan N, Tsoukas M. Applications of bakuchiol in dermatology: systematic review of the literature. J Cosmet Dermatol. 2022;21:6636\u201343. https:\/\/doi.org\/10.1111\/jocd.15420.","journal-title":"J Cosmet Dermatol"},{"key":"1807_CR149","doi-asserted-by":"publisher","first-page":"307","DOI":"10.36849\/JDD.5655","volume":"20","author":"L Brownell","year":"2021","unstructured":"Brownell L, Geen S, E Y, Lee W-L. A clinical study evaluating the efficacy of topical Bakuchiol (UP256) cream on facial acne. J Drugs Dermatol. 2021;20:307\u201310. https:\/\/doi.org\/10.36849\/JDD.5655.","journal-title":"J Drugs Dermatol"},{"key":"1807_CR150","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/bjd.16918","volume":"180","author":"S Dhaliwal","year":"2019","unstructured":"Dhaliwal S, Rybak I, Ellis SR, et al. Prospective, randomized, double-blind assessment of topical bakuchiol and retinol for facial photoageing. Br J Dermatol. 2019;180:289\u201396. https:\/\/doi.org\/10.1111\/bjd.16918.","journal-title":"Br J Dermatol"},{"key":"1807_CR151","doi-asserted-by":"publisher","first-page":"775","DOI":"10.3390\/app12020775","volume":"12","author":"DISP Resende","year":"2022","unstructured":"Resende DISP, Ferreira MS, Lobo JMS, Sousa E, Almeida IF. Skin depigmenting agents in anti-aging cosmetics: a medicinal perspective on emerging ingredients. Appl Sci. 2022;12:775. https:\/\/doi.org\/10.3390\/app12020775.","journal-title":"Appl Sci"},{"key":"1807_CR152","doi-asserted-by":"publisher","first-page":"e141","DOI":"10.1016\/j.jaad.2013.02.022","volume":"69","author":"T Passeron","year":"2013","unstructured":"Passeron T. Long-lasting effect of vascular targeted therapy of melasma. J Am Acad Dermatol. 2013;69:e141\u20132. https:\/\/doi.org\/10.1016\/j.jaad.2013.02.022.","journal-title":"J Am Acad Dermatol"},{"key":"1807_CR153","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.jdermsci.2017.06.018","volume":"88","author":"Y Wang","year":"2017","unstructured":"Wang Y, Viennet C, Robin S, Berthon J-Y, He L, Humbert P. Precise role of dermal fibroblasts on melanocyte pigmentation. J Dermatol Sci. 2017;88:159\u201366. https:\/\/doi.org\/10.1016\/j.jdermsci.2017.06.018.","journal-title":"J Dermatol Sci"},{"key":"1807_CR154","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/CCID.S343332","volume":"15","author":"K Phansuk","year":"2022","unstructured":"Phansuk K, Vachiramon V, Jurairattanaporn N, Chanprapaph K, Rattananukrom T. Dermal pathology in melasma: an update review. Clin Cosmet Investig Dermatol. 2022;15:11\u20139. https:\/\/doi.org\/10.2147\/CCID.S343332.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"1807_CR155","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/jidsymp.2008.7","volume":"13","author":"J-P Ortonne","year":"2008","unstructured":"Ortonne J-P, Bissett DL. Latest insights into skin hyperpigmentation. J Investig Dermatol Symp Proc. 2008;13:10\u20134. https:\/\/doi.org\/10.1038\/jidsymp.2008.7.","journal-title":"J Investig Dermatol Symp Proc"},{"key":"1807_CR156","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/1346-8138.13725","volume":"44","author":"H Sakai","year":"2017","unstructured":"Sakai H, Ando Y, Ikinaga K, Tanaka M. Estimating melanin location in the pigmented skin lesions by hue\u2013saturation\u2013lightness color space values of dermoscopic images. J Dermatol. 2017;44:490\u20138. https:\/\/doi.org\/10.1111\/1346-8138.13725.","journal-title":"J Dermatol"},{"key":"1807_CR157","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/S0190-9622(88)70217-0","volume":"19","author":"JS Weiss","year":"1988","unstructured":"Weiss JS, James WD, Cooper KD. Melanophages in inflammatory skin disease demonstrate the surface phenotype of OKM5+ antigen-presenting cells and activated macrophages. J Am Acad Dermatol. 1988;19:633\u201341. https:\/\/doi.org\/10.1016\/S0190-9622(88)70217-0.","journal-title":"J Am Acad Dermatol"},{"key":"1807_CR158","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00441-013-1577-y","volume":"352","author":"M M\u00fcller","year":"2013","unstructured":"M\u00fcller M, Els\u00e4sser HP. Alterations in the secretory pattern of dermal dendritic cells following melanin uptake. Cell Tissue Res. 2013;352:599\u2013610. https:\/\/doi.org\/10.1007\/s00441-013-1577-y.","journal-title":"Cell Tissue Res"},{"key":"1807_CR159","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.3892\/mmr.2020.10950","volume":"21","author":"C Fu","year":"2020","unstructured":"Fu C, Chen J, Lu J, et al. Roles of inflammation factors in melanogenesis (review). Mol Med Rep. 2020;21:1421\u201330. https:\/\/doi.org\/10.3892\/mmr.2020.10950.","journal-title":"Mol Med Rep"},{"key":"1807_CR160","doi-asserted-by":"publisher","DOI":"10.4103\/ijdvl.IJDVL_633_18","volume":"86","author":"R Sarkar","year":"2020","unstructured":"Sarkar R, Bansal A, Ailawadi P. Future therapies in melasma: what lies ahead? Indian J Dermatol Venereol Leprol. 2020;86:8. https:\/\/doi.org\/10.4103\/ijdvl.IJDVL_633_18.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"1807_CR161","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.103871","volume":"25","author":"E Flori","year":"2022","unstructured":"Flori E, Mastrofrancesco A, Mosca S, et al. Sebocytes contribute to melasma onset. iScience. 2022;25:103871. https:\/\/doi.org\/10.1016\/j.isci.2022.103871.","journal-title":"iScience"},{"key":"1807_CR162","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00235","volume":"9","author":"AC Liberman","year":"2018","unstructured":"Liberman AC, Budzi\u00f1ski ML, Sokn C, Gobbini RP, Steininger A, Arzt E. Regulatory and mechanistic actions of glucocorticoids on T and inflammatory cells. Front Endocrinol (Lausanne). 2018;9:235. https:\/\/doi.org\/10.3389\/fendo.2018.00235.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1807_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174458","volume":"910","author":"J Liu","year":"2021","unstructured":"Liu J, Jiang R, Zhou J, et al. Salicylic acid in ginseng root alleviates skin hyperpigmentation disorders by inhibiting melanogenesis and melanosome transport. Eur J Pharmacol. 2021;910:174458. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174458.","journal-title":"Eur J Pharmacol"},{"key":"1807_CR164","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.3390\/molecules25061324","volume":"25","author":"M S\u00e1nchez","year":"2020","unstructured":"S\u00e1nchez M, Gonz\u00e1lez-Burgos E, Iglesias I, G\u00f3mez-Serranillos MP. Pharmacological update properties of aloe vera and its major active constituents. Molecules. 2020;25:1324. https:\/\/doi.org\/10.3390\/molecules25061324.","journal-title":"Molecules"},{"key":"1807_CR165","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1080\/14764172.2017.1279329","volume":"19","author":"M Ghafarzadeh","year":"2017","unstructured":"Ghafarzadeh M, Eatemadi A. Clinical efficacy of liposome-encapsulated aloe vera on melasma treatment during pregnancy. J Cosmet Laser Ther. 2017;19:181\u20137. https:\/\/doi.org\/10.1080\/14764172.2017.1279329.","journal-title":"J Cosmet Laser Ther"},{"key":"1807_CR166","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1039\/c8md00288f","volume":"9","author":"W Liu","year":"2018","unstructured":"Liu W, Huang S, Li Y, et al. Glycyrrhizic acid from licorice down-regulates inflammatory responses via blocking MAPK and PI3K\/Akt-dependent NF-\u03baB signalling pathways in TPA-induced skin inflammation. Medchemcomm. 2018;9:1502\u201310. https:\/\/doi.org\/10.1039\/c8md00288f.","journal-title":"Medchemcomm"},{"key":"1807_CR167","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1002\/ptr.6178","volume":"32","author":"G Pastorino","year":"2018","unstructured":"Pastorino G, Cornara L, Soares S, Rodrigues F, Oliveira MBPP. Liquorice (Glycyrrhiza glabra): a phytochemical and pharmacological review. Phytother Res. 2018;32:2323\u201339. https:\/\/doi.org\/10.1002\/ptr.6178.","journal-title":"Phytother Res"},{"key":"1807_CR168","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/jocd.12241","volume":"15","author":"FR Grippaudo","year":"2016","unstructured":"Grippaudo FR, Di Russo PP. Effects of topical application of B-resorcinol and glycyrrhetinic acid monotherapy and in combination with fractional CO2 laser treatment for benign hand hyperpigmentation treatment. J Cosmet Dermatol. 2016;15:413\u20139. https:\/\/doi.org\/10.1111\/jocd.12241.","journal-title":"J Cosmet Dermatol"},{"key":"1807_CR169","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1600-0749.1998.tb00494.x","volume":"11","author":"T Yokota","year":"1998","unstructured":"Yokota T, Nishio H, Kubota Y, Mizoguchi M. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Res. 1998;11:355\u201361. https:\/\/doi.org\/10.1111\/j.1600-0749.1998.tb00494.x.","journal-title":"Pigment Cell Res"},{"key":"1807_CR170","first-page":"231","volume":"74","author":"D Liping","year":"2023","unstructured":"Liping D, Ping M, Ying Z, Xinfen C, Liting S, Gang H. Improvement of melasma with glabridin-containing skin brightening product: clinical and in vitro evaluation. J Cosmet Sci. 2023;74:231.","journal-title":"J Cosmet Sci"},{"key":"1807_CR171","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1111\/1346-8138.13458","volume":"43","author":"K Hasegawa","year":"2016","unstructured":"Hasegawa K, Fujiwara R, Sato K, et al. Increased blood flow and vasculature in solar lentigo. J Dermatol. 2016;43:1209\u201313. https:\/\/doi.org\/10.1111\/1346-8138.13458.","journal-title":"J Dermatol"},{"key":"1807_CR172","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/ced.12835","volume":"41","author":"SJ Kim","year":"2016","unstructured":"Kim SJ, Park J-Y, Shibata T, Fujiwara R, Kang HY. Efficacy and possible mechanisms of topical tranexamic acid in melasma. Clin Exp Dermatol. 2016;41:480\u20135. https:\/\/doi.org\/10.1111\/ced.12835.","journal-title":"Clin Exp Dermatol"},{"key":"1807_CR173","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/ced.14115","volume":"45","author":"E Forbat","year":"2020","unstructured":"Forbat E, Al-Niaimi F, Ali FR. The emerging importance of tranexamic acid in dermatology. Clin Exp Dermatol. 2020;45:445\u20139. https:\/\/doi.org\/10.1111\/ced.14115.","journal-title":"Clin Exp Dermatol"},{"key":"1807_CR174","doi-asserted-by":"publisher","first-page":"776","DOI":"10.2340\/00015555-2668","volume":"97","author":"HJ Kim","year":"2017","unstructured":"Kim HJ, Moon SH, Cho SH, Lee JD, Kim HS. Efficacy and safety of tranexamic acid in melasma: a meta-analysis and systematic review. Acta Derm Venereol. 2017;97:776\u201381. https:\/\/doi.org\/10.2340\/00015555-2668.","journal-title":"Acta Derm Venereol"},{"key":"1807_CR175","doi-asserted-by":"publisher","first-page":"150","DOI":"10.3109\/14764172.2012.685478","volume":"14","author":"P Kanechorn Na Ayuthaya","year":"2012","unstructured":"Kanechorn Na Ayuthaya P, Niumphradit N, Manosroi A, Nakakes A. Topical 5% tranexamic acid for the treatment of melasma in Asians: a double-blind randomized controlled clinical trial. J Cosmet Laser Ther. 2012;14:150\u20134. https:\/\/doi.org\/10.3109\/14764172.2012.685478.","journal-title":"J Cosmet Laser Ther"},{"key":"1807_CR176","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/php.12400","volume":"91","author":"HJ Kim","year":"2015","unstructured":"Kim HJ, Yonezawa T, Teruya T, Woo J-T, Cha B-Y. Nobiletin, a polymethoxy flavonoid, reduced endothelin-1 plus SCF-induced pigmentation in human melanocytes. Photochem Photobiol. 2015;91:379\u201386. https:\/\/doi.org\/10.1111\/php.12400.","journal-title":"Photochem Photobiol"},{"key":"1807_CR177","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.jdermsci.2012.11.590","volume":"69","author":"Y Wakabayashi","year":"2013","unstructured":"Wakabayashi Y, Nakajima H, Imokawa G. Abrogating effect of N-linked carbohydrate modifiers on the stem cell factor and endothelin-1-stimulated epidermal pigmentation in human epidermal equivalents. J Dermatol Sci. 2013;69:215\u201328. https:\/\/doi.org\/10.1016\/j.jdermsci.2012.11.590.","journal-title":"J Dermatol Sci"},{"key":"1807_CR178","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1248\/bpb.24.688","volume":"24","author":"A Hachiya","year":"2001","unstructured":"Hachiya A, Kobayashi A, Ohuchi A, Kitahara T, Takema Y. The inhibitory effect of an extract of Sanguisorba officinalis L. on ultraviolet B-induced pigmentation via the suppression of endothelin-converting enzyme-1alpha. Biol Pharm Bull. 2001;24:688\u201392. https:\/\/doi.org\/10.1248\/bpb.24.688.","journal-title":"Biol Pharm Bull"},{"key":"1807_CR179","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20153666","volume":"20","author":"G Imokawa","year":"2019","unstructured":"Imokawa G. Melanocyte activation mechanisms and rational therapeutic treatments of solar lentigos. Int J Mol Sci. 2019;20:3666. https:\/\/doi.org\/10.3390\/ijms20153666.","journal-title":"Int J Mol Sci"},{"issue":"Suppl 2","key":"1807_CR180","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/jdv.19719","volume":"38","author":"T Hakozaki","year":"2024","unstructured":"Hakozaki T, Wang J, Laughlin T, Jarrold B, Zhao W, Furue M. Role of interleukin-6 and endothelin-1 receptors in enhanced melanocyte dendricity of facial spots and suppression of their ligands by niacinamide and tranexamic acid. J Eur Acad Dermatol Venereol. 2024;38(Suppl 2):3\u201310. https:\/\/doi.org\/10.1111\/jdv.19719.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1807_CR181","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/j.1365-2133.2006.07179.x","volume":"154","author":"HY Kang","year":"2006","unstructured":"Kang HY, Hwang JS, Lee JY, et al. The dermal stem cell factor and c-kit are overexpressed in melasma. Br J Dermatol. 2006;154:1094\u20139. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07179.x.","journal-title":"Br J Dermatol"},{"key":"1807_CR182","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/JID.2015.365","volume":"136","author":"M Kim","year":"2016","unstructured":"Kim M, Han JH, Kim J-H, Park TJ, Kang HY. Secreted frizzled-related protein 2 (sFRP2) functions as a melanogenic stimulator; the role of sFRP2 in UV-induced hyperpigmentary disorders. J Invest Dermatol. 2016;136:236\u201344. https:\/\/doi.org\/10.1038\/JID.2015.365.","journal-title":"J Invest Dermatol"},{"key":"1807_CR183","doi-asserted-by":"publisher","first-page":"3723","DOI":"10.31557\/APJCP.2019.20.12.3723","volume":"20","author":"A Atef","year":"2019","unstructured":"Atef A, El-Rashidy MA, Abdel Azeem A, Kabel AM. The role of stem cell factor in hyperpigmented skin lesions. Asian Pac J Cancer Prev. 2019;20:3723\u20138. https:\/\/doi.org\/10.31557\/APJCP.2019.20.12.3723.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1807_CR184","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.bbrc.2009.09.124","volume":"390","author":"M Cho","year":"2009","unstructured":"Cho M, Ryu M, Jeong Y, et al. Cardamonin suppresses melanogenesis by inhibition of Wnt\/beta-catenin signaling. Biochem Biophys Res Commun. 2009;390:500\u20135. https:\/\/doi.org\/10.1016\/j.bbrc.2009.09.124.","journal-title":"Biochem Biophys Res Commun"},{"key":"1807_CR185","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00762-6","volume":"7","author":"J Liu","year":"2022","unstructured":"Liu J, Xiao Q, Xiao J, et al. Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2022;7:3. https:\/\/doi.org\/10.1038\/s41392-021-00762-6.","journal-title":"Signal Transduct Target Ther"},{"key":"1807_CR186","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1111\/ics.12529","volume":"41","author":"R Sch\u00fctz","year":"2019","unstructured":"Sch\u00fctz R, Rawlings AV, Wandeler E, et al. Bio-derived hydroxystearic acid ameliorates skin age spots and conspicuous pores. Int J Cosmet Sci. 2019;41:240\u201356. https:\/\/doi.org\/10.1111\/ics.12529.","journal-title":"Int J Cosmet Sci"},{"key":"1807_CR187","doi-asserted-by":"publisher","first-page":"58","DOI":"10.31491\/apt.2020.03.014","volume":"2","author":"Y Dou","year":"2020","unstructured":"Dou Y, Lee A, Zhu L, Morton J, Ladiges W. The potential of GHK as an anti-aging peptide. Aging Pathobiol Ther. 2020;2:58\u201361. https:\/\/doi.org\/10.31491\/apt.2020.03.014.","journal-title":"Aging Pathobiol Ther"},{"key":"1807_CR188","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/648108","volume":"2015","author":"L Pickart","year":"2015","unstructured":"Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. BioMed Res Int. 2015;2015:648108. https:\/\/doi.org\/10.1155\/2015\/648108.","journal-title":"BioMed Res Int"},{"key":"1807_CR189","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41598-019-57159-3","volume":"10","author":"J Park","year":"2020","unstructured":"Park J, Jung H, Jang B, Song H-K, Han I-O, Oh E-S. D-tyrosine adds an anti-melanogenic effect to cosmetic peptides. Sci Rep. 2020;10:262. https:\/\/doi.org\/10.1038\/s41598-019-57159-3.","journal-title":"Sci Rep"},{"key":"1807_CR190","doi-asserted-by":"publisher","first-page":"20240","DOI":"10.1038\/s41598-020-76376-9","volume":"10","author":"B Sadaqat","year":"2020","unstructured":"Sadaqat B, Khatoon N, Malik AY, et al. Enzymatic decolorization of melanin by lignin peroxidase from Phanerochaete chrysosporium. Sci Rep. 2020;10:20240. https:\/\/doi.org\/10.1038\/s41598-020-76376-9.","journal-title":"Sci Rep"},{"key":"1807_CR191","doi-asserted-by":"publisher","unstructured":"Falade AO, Nwodo UU, Iweriebor BC, Green E, Mabinya LV, Okoh AI. Lignin peroxidase functionalities and prospective applications. Microbiologyopen. 2017;6. https:\/\/doi.org\/10.1002\/mbo3.394","DOI":"10.1002\/mbo3.394"},{"key":"1807_CR192","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1021\/acs.biomac.3c00123","volume":"24","author":"H Gye","year":"2023","unstructured":"Gye H, Baek H, Han S, et al. Recombinant lignin peroxidase with superior thermal stability and melanin decolorization efficiency in a typical human skin-mimicking environment. Biomacromol. 2023;24:2633\u201342. https:\/\/doi.org\/10.1021\/acs.biomac.3c00123.","journal-title":"Biomacromol"},{"key":"1807_CR193","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ijpharm.2017.12.030","volume":"537","author":"L Yang","year":"2018","unstructured":"Yang L, Yan S, Zhang Y, et al. Novel enzyme formulations for improved pharmacokinetic properties and anti-inflammatory efficacies. Int J Pharm. 2018;537:268\u201377. https:\/\/doi.org\/10.1016\/j.ijpharm.2017.12.030.","journal-title":"Int J Pharm"},{"key":"1807_CR194","doi-asserted-by":"publisher","DOI":"10.1111\/exd.15008","volume":"33","author":"NS Nascimento","year":"2024","unstructured":"Nascimento NS, Torres-Obreque KM, Oliveira CA, et al. Enzymes for dermatological use. Exp Dermatol. 2024;33:e15008. https:\/\/doi.org\/10.1111\/exd.15008.","journal-title":"Exp Dermatol"},{"key":"1807_CR195","doi-asserted-by":"publisher","first-page":"406","DOI":"10.4103\/idoj.IDOJ_187_17","volume":"8","author":"N Sarma","year":"2017","unstructured":"Sarma N, Chakraborty S, Poojary S, et al. Evidence-based review, grade of recommendation, and suggested treatment recommendations for melasma. Indian Dermatol Online J. 2017;8:406. https:\/\/doi.org\/10.4103\/idoj.IDOJ_187_17.","journal-title":"Indian Dermatol Online J"},{"key":"1807_CR196","doi-asserted-by":"publisher","first-page":"247","DOI":"10.4103\/0974-2077.104912","volume":"5","author":"R Sarkar","year":"2012","unstructured":"Sarkar R, Bansal S, Garg VK. Chemical peels for melasma in dark-skinned patients. J Cutan Aesthet Surg. 2012;5:247\u201353. https:\/\/doi.org\/10.4103\/0974-2077.104912.","journal-title":"J Cutan Aesthet Surg"},{"key":"1807_CR197","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ijwd.2017.01.004","volume":"3","author":"MK Trivedi","year":"2017","unstructured":"Trivedi MK, Yang FC, Cho BK. A review of laser and light therapy in melasma. Int J Womens Dermatol. 2017;3:11\u201320. https:\/\/doi.org\/10.1016\/j.ijwd.2017.01.004.","journal-title":"Int J Womens Dermatol"},{"key":"1807_CR198","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/jdv.15497","volume":"33","author":"T Passeron","year":"2019","unstructured":"Passeron T, Genedy R, Salah L, et al. Laser treatment of hyperpigmented lesions: position statement of the European Society of Laser in Dermatology. J Eur Acad Dermatol Venereol. 2019;33:987\u20131005. https:\/\/doi.org\/10.1111\/jdv.15497.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1807_CR199","first-page":"32","volume":"3","author":"MI Rendon","year":"2010","unstructured":"Rendon MI, Berson DS, Cohen JL, Roberts WE, Starker I, Wang B. Evidence and considerations in the application of chemical peels in skin disorders and aesthetic resurfacing. J Clin Aesthet Dermatol. 2010;3:32\u201343.","journal-title":"J Clin Aesthet Dermatol"},{"key":"1807_CR200","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12010138","author":"A Jesus","year":"2023","unstructured":"Jesus A, Mota S, Torres A, et al. Antioxidants in sunscreens: which and what for? Antioxidants. 2023. https:\/\/doi.org\/10.3390\/antiox12010138.","journal-title":"Antioxidants"},{"key":"1807_CR201","doi-asserted-by":"publisher","DOI":"10.1111\/phpp.70062","author":"J Krutmann","year":"2025","unstructured":"Krutmann J, Brown A, Passeron T, et al. PINGing Sunshine: a review of the evidence for adding non-filtering photoprotective ingredients to sunscreens. Photodermatol Photoimmunol Photomed. 2025. https:\/\/doi.org\/10.1111\/phpp.70062.","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"1807_CR202","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1111\/j.1365-4632.2003.02017.x","volume":"42","author":"IL Guevara","year":"2003","unstructured":"Guevara IL, Pandya AG. Safety and efficacy of 4% hydroquinone combined with 10% glycolic acid, antioxidants, and sunscreen in the treatment of melasma. Int J Dermatol. 2003;42:966\u201372. https:\/\/doi.org\/10.1111\/j.1365-4632.2003.02017.x.","journal-title":"Int J Dermatol"},{"key":"1807_CR203","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1111\/jocd.14271","volume":"21","author":"M Cantelli","year":"2022","unstructured":"Cantelli M, Ferrillo M, Granger C, Fabbrocini G. An open-label, investigator-initiated, single-center, prospective, pilot clinical study to evaluate the efficacy of a skin whitening serum applied twice daily combined with a spot-preventing SPF50+ sunscreen in healthy female subjects with melasma hyperpigmentation. J Cosmet Dermatol. 2022;21:1523\u201332. https:\/\/doi.org\/10.1111\/jocd.14271.","journal-title":"J Cosmet Dermatol"},{"key":"1807_CR204","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s40257-019-00488-w","volume":"21","author":"J McKesey","year":"2020","unstructured":"McKesey J, Tovar-Garza A, Pandya AG. Melasma treatment: an evidence-based review. Am J Clin Dermatol. 2020;21:173\u2013225. https:\/\/doi.org\/10.1007\/s40257-019-00488-w.","journal-title":"Am J Clin Dermatol"},{"key":"1807_CR205","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.70205","volume":"24","author":"H Hu","year":"2025","unstructured":"Hu H, Zhou P, Yao H, et al. Efficacy and safety of generic fluocinolone acetonide, hydroquinone, and tretinoin cream compared with TRI-LUMA for the treatment of moderate-to-severe melasma in Chinese patients: a randomized, single-center, placebo-controlled trial. J Cosmet Dermatol. 2025;24:e70205. https:\/\/doi.org\/10.1111\/jocd.70205.","journal-title":"J Cosmet Dermatol"},{"key":"1807_CR206","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1111\/jdv.19455","volume":"37","author":"C Bertold","year":"2023","unstructured":"Bertold C, Fontas E, Singh T, et al. Efficacy and safety of a novel triple combination cream compared to Kligman\u2019s trio for melasma: a 24-week double-blind prospective randomized controlled trial. J Eur Acad Dermatol Venereol. 2023;37:2601\u20137. https:\/\/doi.org\/10.1111\/jdv.19455.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1807_CR207","first-page":"476","volume":"15","author":"JH Herndon","year":"2016","unstructured":"Herndon JH, Jiang LI, Kononov T, Fox T. An open label clinical trial to evaluate the efficacy and tolerance of a retinol and vitamin\u00a0C facial regimen in women with mild-to-moderate hyperpigmentation and photodamaged facial skin. J Drugs Dermatol. 2016;15:476\u201382.","journal-title":"J Drugs Dermatol"},{"key":"1807_CR208","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0214714","volume":"14","author":"F Arginelli","year":"2019","unstructured":"Arginelli F, Greco M, Ciardo S, et al. Efficacy of D-pigment dermocosmetic lightening product for solar lentigo lesions of the hand: a randomized controlled trial. PLoS ONE. 2019;14:e0214714. https:\/\/doi.org\/10.1371\/journal.pone.0214714.","journal-title":"PLoS ONE"},{"key":"1807_CR209","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.16735","volume":"24","author":"AL Demessant-Flavigny","year":"2025","unstructured":"Demessant-Flavigny AL, Petkar G, Jodun D, Le Dantec G, Le Floc\u2019h C, Kerob D. Efficacy of a 2-MNG-containing depigmenting serum in the treatment of post-inflammatory hyperpigmentation. J Cosmet Dermatol. 2025;24:e16735. https:\/\/doi.org\/10.1111\/jocd.16735.","journal-title":"J Cosmet Dermatol"},{"key":"1807_CR210","first-page":"18","volume":"18","author":"H Dumbuya","year":"2025","unstructured":"Dumbuya H, Alexis A, Lynch S, Callender V, Desai SR, Draelos ZD. Efficacy of a 2-MNG-containing serum and sunscreen regimen on improving facial dyschromia in women with skin of color. J Clin Aesthet Dermatol. 2025;18:18\u201324.","journal-title":"J Clin Aesthet Dermatol"},{"key":"1807_CR211","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1007\/s13555-025-01473-4","volume":"15","author":"T Passeron","year":"2025","unstructured":"Passeron T, Kerob D, Le Dantec G, et al. Efficacy and tolerability of a new facial 2-mercaptonicotinoyl glycine-containing depigmenting serum versus hydroquinone 4% over 3-month treatment of facial melasma. Dermatol Ther. 2025;15:2379\u201390. https:\/\/doi.org\/10.1007\/s13555-025-01473-4.","journal-title":"Dermatol Ther"},{"key":"1807_CR212","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-025-01628-3","author":"R Li","year":"2025","unstructured":"Li R, Li B, Chen Y, et al. Evaluation of the efficacy of a 2-MNG-containing serum on improving skin tone and hyperpigmentation. Dermatol Ther (Heidelb). 2025. https:\/\/doi.org\/10.1007\/s13555-025-01628-3.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1807_CR213","first-page":"454","volume":"18","author":"S Desai","year":"2019","unstructured":"Desai S, Ayres E, Bak H, et al. Effect of a tranexamic acid, kojic acid, and niacinamide containing serum on facial dyschromia: a clinical evaluation. J Drugs Dermatol. 2019;18:454\u20139.","journal-title":"J Drugs Dermatol"},{"key":"1807_CR214","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/jdv.16150","volume":"34","author":"E Bronzina","year":"2020","unstructured":"Bronzina E, Clement A, Marie B, Fook Chong KT, Faure P, Passeron T. Efficacy and tolerability on melasma of a topical cosmetic product acting on melanocytes, fibroblasts and endothelial cells: a randomized comparative trial against 4% hydroquinone. J Eur Acad Dermatol Venereol. 2020;34:897\u2013903. https:\/\/doi.org\/10.1111\/jdv.16150.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1807_CR215","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3390\/ijms20040956","volume":"20","author":"J-I Na","year":"2019","unstructured":"Na J-I, Shin J-W, Choi H-R, Kwon S-H, Park K-C. Resveratrol as a multifunctional topical hypopigmenting agent. Int J Mol Sci. 2019;20:956. https:\/\/doi.org\/10.3390\/ijms20040956.","journal-title":"Int J Mol Sci"},{"key":"1807_CR216","first-page":"1467","volume":"13","author":"P Farris","year":"2014","unstructured":"Farris P, Yatskayer M, Chen N, Krol Y, Oresajo C. Evaluation of efficacy and tolerance of a nighttime topical antioxidant containing resveratrol, baicalin, and vitamin\u00a0E for treatment of mild to moderately photodamaged skin. J Drugs Dermatol. 2014;13:1467\u201372.","journal-title":"J Drugs Dermatol"},{"key":"1807_CR217","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1111\/jocd.13323","volume":"19","author":"J Kim","year":"2020","unstructured":"Kim J, Kim J, Lee YI, Almurayshid A, Jung JY, Lee JH. Effect of a topical antioxidant serum containing vitamin\u00a0C, vitamin\u00a0E, and ferulic acid after Q-switched 1064-nm Nd:YAG laser for treatment of environment-induced skin pigmentation. J Cosmet Dermatol. 2020;19:2576\u201382. https:\/\/doi.org\/10.1111\/jocd.13323.","journal-title":"J Cosmet Dermatol"},{"key":"1807_CR218","doi-asserted-by":"publisher","DOI":"10.1186\/1471-5945-12-18","volume":"12","author":"T Altaei","year":"2012","unstructured":"Altaei T. The treatment of melasma by silymarin cream. BMC Dermatol. 2012;12:18. https:\/\/doi.org\/10.1186\/1471-5945-12-18.","journal-title":"BMC Dermatol"},{"key":"1807_CR219","first-page":"52","volume":"12","author":"A Dahl","year":"2013","unstructured":"Dahl A, Yatskayer M, Raab S, Oresajo C. Tolerance and efficacy of a product containing ellagic and salicylic acids in reducing hyperpigmentation and dark spots in comparison with 4% hydroquinone. J Drugs Dermatol. 2013;12:52\u20138.","journal-title":"J Drugs Dermatol"},{"key":"1807_CR220","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/j.1346-8138.2008.00522.x","volume":"35","author":"I Ertam","year":"2008","unstructured":"Ertam I, Mutlu B, Unal I, Alper S, Kiv\u00e7ak B, Ozer O. Efficiency of ellagic acid and arbutin in melasma: a randomized, prospective, open-label study. J Dermatol. 2008;35:570\u20134. https:\/\/doi.org\/10.1111\/j.1346-8138.2008.00522.x.","journal-title":"J Dermatol"},{"key":"1807_CR221","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1055\/a-1170-7785","volume":"86","author":"M Kanlayavattanakul","year":"2020","unstructured":"Kanlayavattanakul M, Chongnativisit W, Chaikul P, Lourith N. Phenolic-rich pomegranate peel extract: in vitro, cellular, and in vivo activities for skin hyperpigmentation treatment. Planta Med. 2020;86:749\u201359. https:\/\/doi.org\/10.1055\/a-1170-7785.","journal-title":"Planta Med"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01807-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01807-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01807-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T03:24:34Z","timestamp":1781753074000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-026-01807-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,3]]},"references-count":221,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1807"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01807-w","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,3]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Christine Duval, Jie Qiu, Emilie Warrick, Peggy Sextius, Isabelle Castiel, and Francoise Bernerd are employees of L\u2019Or\u00e9al. Leihong Xiang has received honoraria from L\u2019Or\u00e9al, Sinclair, Allergan, Galderma, YA-MAN, Botanee, ISIS Pharma and Beiersdorf. Thierry Passeron has received honoraria from L\u2019Or\u00e9al, Galderma, Beiersdorf, Hyphens, ISIS Pharma, ISDIN, NAOS, Pierre Fabre, SUN Pharma, SVR and Symrise.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}